Viatris Earnings miss, Revenue beats In Q1



© Reuters. Viatris Earnings miss, Revenue beats In Q1

Investing.com – Viatris reported on Monday first quarter that missed analysts’ forecasts and revenue that topped expectations.

Viatris announced earnings per share of $-0.86 on revenue of $4.43B. Analysts polled by Investing.com anticipated EPS of $0.799 on revenue of $4.2B.

Viatris shares are down 24.87% from the beginning of the year and are trading at $14.08 , down-from-52-week-high.They are under-performing the S&P 500 which is up 12.69% from the start of the year.

Viatris follows other major Healthcare sector earnings this month

Viatris’s report follows an earnings beat by J&J on April 20, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.34 on revenue of $21.98B.

Pfizer had beat expectations on May 4 with first quarter EPS of $0.93 on revenue of $14.58B, compared to forecast for EPS of $0.7759 on revenue of $13.65B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

READ  China pushes to diversify stock market investment - Securities Times





READ SOURCE

LEAVE A REPLY

Please enter your comment!
Please enter your name here